RuvC inhibitors represent a class of chemical compounds designed to interfere with the activity of the RuvC protein, an essential component of the bacterial RecBCD pathway involved in DNA repair and recombination processes. The RecBCD pathway plays a crucial role in the maintenance of genomic integrity by ensuring the accurate repair of DNA damage, such as double-strand breaks and the resolution of Holliday junctions during genetic recombination. RuvC, specifically, is a nuclease enzyme responsible for cleaving the Holliday junctions, allowing the separated DNA strands to recombine properly. Inhibiting RuvC disrupts the precise execution of these DNA repair processes, potentially leading to genomic instability and cell death in bacteria.
Chemically, RuvC inhibitors are designed to target the active site of the RuvC protein, where they can either block its binding to DNA or interfere with its enzymatic activity. These inhibitors often employ structural mimetics, such as small molecules or peptides, to competitively bind to RuvC, preventing it from engaging with its DNA substrate effectively. By doing so, they impede the cleavage of Holliday junctions and disrupt the timely resolution of recombination intermediates. RuvC inhibitors have been valuable tools in molecular biology research, aiding in the elucidation of DNA repair mechanisms and providing insights into the fundamental processes governing genetic recombination in bacteria.
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
BAY 87-2243 | 1227158-85-1 | sc-507483 | 5 mg | $100.00 | ||
BAY 87-2243 inhibits RUVc by disrupting DNA repair processes. | ||||||
Cisplatin | 15663-27-1 | sc-200896 sc-200896A | 100 mg 500 mg | $76.00 $216.00 | 101 | |
Cisplatin forms DNA crosslinks, preventing RUVc from acting. | ||||||
Carboplatin | 41575-94-4 | sc-202093 sc-202093A | 25 mg 100 mg | $47.00 $132.00 | 14 | |
Carboplatin inhibits RUVc by forming DNA adducts. | ||||||
Etoposide (VP-16) | 33419-42-0 | sc-3512B sc-3512 sc-3512A | 10 mg 100 mg 500 mg | $32.00 $170.00 $385.00 | 63 | |
Etoposide topoisomerase II, a target of RUVc, leading to DNA damage. | ||||||
Mitoxantrone | 65271-80-9 | sc-207888 | 100 mg | $279.00 | 8 | |
Mitoxantrone intercalates into DNA, disrupting RUVc function. | ||||||
Topotecan Hydrochloride | 119413-54-6 | sc-204919 sc-204919A | 1 mg 5 mg | $44.00 $100.00 | 2 | |
Topotecan also targets topoisomerase I, inhibiting RUVc. | ||||||
Camptothecin | 7689-03-4 | sc-200871 sc-200871A sc-200871B | 50 mg 250 mg 100 mg | $57.00 $182.00 $92.00 | 21 | |
Camptothecin inhibits topoisomerase I, disrupting DNA repair. | ||||||
Belinostat | 414864-00-9 | sc-269851 sc-269851A | 10 mg 100 mg | $153.00 $561.00 | ||
Belinostat inhibits HDAC enzymes, affecting DNA repair. | ||||||
Olaparib | 763113-22-0 | sc-302017 sc-302017A sc-302017B | 250 mg 500 mg 1 g | $206.00 $299.00 $485.00 | 10 | |
Olaparib targets PARP enzymes, involved in DNA repair. | ||||||
Rucaparib | 283173-50-2 | sc-507419 | 5 mg | $150.00 | ||
Rucaparib inhibits PARP, disrupting DNA damage repair. | ||||||